Impact of maternal undernutrition and fetal number on glucocorticoid, growth hormone and insulin-like growth factor receptor mRNA abundance in the ovine fetal kidney.
Epidemiological and animal studies strongly indicate that the environment experienced in utero determines, in part, an individual's likelihood of developing cardiovascular disease in later life. This risk has been further linked to impaired kidney function, as a result of compromised development during fetal life. The present study therefore examined the influence of maternal nutrient restriction (NR), targeted at specific periods of kidney development during early to mid gestation, on the mRNA abundance of receptors for glucocorticoid (GCR), growth hormone (GHR) and insulin-like growth factors-I (IGF-IR) and -II (IGF-IIR), and the IGF-I and -II ligands. This was undertaken in both singleton and twin fetuses. At conception ewes were randomly allocated to either an adequately fed control group or one of four nutrient-restricted groups that were fed half the control amount from 0 to 30, 31 to 65, 66 to 110 or 0 to 110 days gestation. At 110 days gestation all ewes were humanely euthanased and fetal kidneys and surrounding adipose tissue sampled. There was no effect of NR or fetal number on kidney weight, shape or nephron number, but the surrounding fat mass was increased in singleton fetuses exposed to NR for 110 days. An increase in kidney mRNA abundance with NR only occurred in singleton fetuses where IGF-IR mRNA was enhanced with NR from 66-110 days gestation. In twin fetuses, NR had no effect on mRNA abundance. However, for all genes examined mRNA expression was lower in the kidneys of twin compared with singleton fetuses following NR, and the magnitude of the effect was dependent on the timing of NR. In conclusion, the abundance of mRNA for receptors which regulate fetal kidney development are lower in twin animals compared with singletons following periods of nutrient deficiency. This may impact on later kidney development and function.
Brennan
K A
KA
Centre for Reproduction and Early Life, Institute of Clinical Research, Queen's Medical Centre, Nottingham NG7 2UH, UK.
Gopalakrishnan
G S
GS
Kurlak
L
L
Rhind
S M
SM
Kyle
C E
CE
Brooks
A N
AN
Rae
M T
MT
Olson
D M
DM
Stephenson
T
T
Symonds
M E
ME
D000818:Animals; D005260:Female; D007668:Kidney / Q000196:embryology* / Q000378:metabolism; D008098:Litter Size; D039382:Maternal Nutritional Physiological Phenomena; D009399:Nephrons / Q000033:anatomy & histology; D009929:Organ Size; D010920:Placenta / Q000033:anatomy & histology; D011247:Pregnancy; D012333:RNA, Messenger / Q000032:analysis / Q000378:metabolism; D017526:Receptor, IGF Type 1 / Q000235:genetics; D017527:Receptor, IGF Type 2 / Q000235:genetics; D011965:Receptors, Glucocorticoid / Q000235:genetics*; D017451:Receptors, Somatomedin / Q000235:genetics*; D011986:Receptors, Somatotropin / Q000235:genetics*; D012756:Sheep / Q000196:embryology*
D012333:RNA, Messenger; D017527:Receptor, IGF Type 2; D011965:Receptors, Glucocorticoid; D017451:Receptors, Somatomedin; D011986:Receptors, Somatotropin; D017526:Receptor, IGF Type 1